News and Analysis | Published:

Anti-ageing pipeline starts to mature

Nature Reviews Drug Discovery volume 17, pages 609612 (2018) | Download Citation

Ongoing and upcoming clinical trials of metformin, mTOR inhibitors and senescent cell-killing drugs could prove that ageing and ageing-related diseases are viable drug discovery indications.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd.2018.134

Authors

  1. Search for Asher Mullard in:

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing